The Global Lifescience Reagent Market, by Product Type (Biochemical Reagents, Cell Culture Reagents, Genomic Reagents, Chromatography Reagents, Flow Cytometry Reagents, PCR Reagents, Electrophoresis Reagents, Signal Transduction Reagents, and Others), by End User (Diagnostics Laboratory, Contract Research Manufacturers, Academic and Research Institute, and Others ), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued at US$ 33,754.0 million in 2017, and is projected to exhibit a CAGR of 7.3%, during the forecast period (2018 - 2026).
Increasing number of lifescience research institutes is contributing to global lifescience reagent market growth. For instance, in October 2016, UMass Amherst (University of Massachusetts Amherst) launched Institute for Applied Lifesciences (IALS). IALS is a lifesciences laboratory research center equipped with research facilities and state-of-the-art equipment for research and development in collaboration with industry partners to develop new methods and technologies that can be transformed into commercial services and products.
Manufacturers are engaged in developing biological reagents for various research purposes, which is expected to drive the global lifescience reagent market growth. For instance, in June 2014, Bio-Rad Laboratories, Inc. launched SsoAdvanced PreAmp Supermix and PrimePCR PreAmp Assays. The new reagent, SsoAdvanced PreAmp Supermix, has been formulated to permit unbiased, target-specific preamplification of cDNA or genomic DNA (gDNA), allowing researchers to stretch their limited nucleic acid samples. PrimePCR PreAmp assays are wet-lab validated preamplification primers that work with the supermix to ensure optimal preamplification for real-time polymerase chain reaction (PCR). Moreover, biotechnology and pharmaceutical manufacturers are focusing on the acquisitions, in order to enhance their lifescience product portfolio, which in turn contribute to increase in global lifescience reagent market share. For instance, in February 2018, LGC Limited acquired Lucigen Corporation, a developer, manufacturer, and supplier of molecular biology enzymes, reagents, and kits. With this acquisition, LCG is expected to strengthen its reagents offering to get access to next-generation sequencing (NGS) and gene editing industry.
- The global lifescience reagent market is expected to expand at a CAGR of 7.3% during the forecast period (2018–2026), owing to increasing lifescience researches to study the human biology.
- Among the product type, genomic reagents is expected to hold a significant market share in lifescience reagent market over the forecast period, owing to increasing product launches for genomic reagents. For instance, in July 2018, New England Biolabs launched the NEBNext Direct Custom Ready Panels. The new panels are coupled with the company’s NEBNext Direct target enrichment technology.
- Major players operating in the global lifescience reagent market include F. Hoffmann-La Roche Ltd., Danaher Corporation, Abbott Laboratories, Merck KGaA, Bio-Rad Laboratories, GE Healthcare, Siemens Healthineers, Becton, Dickinson and Company, Agilent Technologies Inc., Perkin Elmer Inc., Waters Corporation, Ortho Clinical Diagnostics, bioMérieux SA, and Sysmex Corporation
